Infectious Diseases of Poverty

Papers
(The H4-Index of Infectious Diseases of Poverty is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Patented technologies for schistosomiasis control and prevention filed by Chinese applicants283
Coverage of community-wide mass drug administration platforms for soil-transmitted helminths in Benin, India, and Malawi: findings from the DeWorm3 project121
Discrepancies between self-reported medication in adherence and indirect measurement adherence among patients undergoing antiretroviral therapy: a systematic review98
Accelerating Pneumococcal Conjugate Vaccine introductions in Indonesia: key learnings from 2017 to 202288
Optimisation of the DNA dipstick as a rapid extraction method for Schistosoma japonicum in infected mice samples and spiked human clinical samples88
Increased clonal dissemination of OXA-232-producing ST15 Klebsiella pneumoniae in Zhejiang, China from 2018 to 202181
Molecular epidemiology and phylogenetic analysis of influenza viruses A (H3N2) and B/Victoria during the COVID-19 pandemic in Guangdong, China66
Prevalence and spatial distribution patterns of human echinococcosis at the township level in Sichuan Province, China65
Establishment and evaluation of an overlap extension polymerase chain reaction technique for rapid and efficient detection of drug-resistance in Mycobacterium tuberculosis64
Key immunity characteristics of diverse stages of brucellosis in rural population from Inner Mongolia, China63
Epidemiology and evolution of Middle East respiratory syndrome coronavirus, 2012–202051
Prevalence and correlations of schistosomiasis mansoni and schistosomiasis haematobium among humans and intermediate snail hosts: a systematic review and meta-analysis48
Social protection as a right of people affected by tuberculosis: a scoping review and conceptual framework46
Immediate and long-term outcomes after treat-all among people living with HIV in China: an interrupted time series analysis45
Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials45
Uptake of hepatitis C direct-acting antiviral treatment in China: a retrospective study from 2017 to 202145
The rapid and efficient strategy for SARS-CoV-2 Omicron transmission control: analysis of outbreaks at the city level44
Patterns of human social contact and mask wearing in high-risk groups in China44
COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status44
Multi-level determinants of failure to receive timely and complete measles vaccinations in Southwest China: a mixed methods study41
Impact of 1,7-malaria reactive community-based testing and response (1,7-mRCTR) approach on malaria prevalence in Tanzania38
Mindfulness-based online intervention on mental health and quality of life among COVID-19 patients in China: an intervention design38
The pathology, phylogeny, and epidemiology of Echinococcus ortleppi (G5 genotype): a new case report of echinococcosis in China36
The role of personality, social economic and prevention strategy effects on health-related quality of life among people living with HIV/AIDS36
Mitigating host microRNA interference to enhance mRNA vaccine efficacy in public health interventions32
Correction to: Risk factors for developing severe COVID-19 in China: an analysis of disease surveillance data32
HIV incidence and risk factors among transgender women and cisgender men who have sex with men in two cities of China: a prospective cohort study32
MODELS: a six-step framework for developing an infectious disease model32
Life expectancy and healthy life expectancy of patients with advanced schistosomiasis in Hunan Province, China30
Treatment and prevention of epilepsy in onchocerciasis-endemic areas is urgently needed30
0.027094125747681